Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Approaches toward peptide-based immunotherapy of autoimmune diseases.

× No keyword cloud information.

42 in total

Review 1. Drug delivery.

Authors: L Illum; S S Davis
Journal: Curr Opin Biotechnol Date: 1991-04 Impact factor: 9.740

Review 2. The cell biology of antigen processing and presentation.

Authors: F M Brodsky; L E Guagliardi
Journal: Annu Rev Immunol Date: 1991 Impact factor: 28.527

3. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

Authors: A A Vandenbark; G Hashim; H Offner
Journal: Nature Date: 1989-10-12 Impact factor: 49.962

Review 4. Peptide competition for antigen presentation.

Authors: L Adorini; Z A Nagy
Journal: Immunol Today Date: 1990-01

5. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.

Authors: K W Wucherpfennig; K Ota; N Endo; J G Seidman; A Rosenzweig; H L Weiner; D A Hafler
Journal: Science Date: 1990-05-25 Impact factor: 47.728

6. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors: B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal: Proc Natl Acad Sci U S A Date: 1991-10-15 Impact factor: 11.205

7. T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis.

Authors: L Desquenne-Clark; T R Esch; L Otvos; E Heber-Katz
Journal: Proc Natl Acad Sci U S A Date: 1991-08-15 Impact factor: 11.205

8. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

Authors: D Elias; T Reshef; O S Birk; R van der Zee; M D Walker; I R Cohen
Journal: Proc Natl Acad Sci U S A Date: 1991-04-15 Impact factor: 11.205

9. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.

Authors: L Adorini; J Moreno; F Momburg; G J Hämmerling; J C Guéry; A Valli; S Fuchs
Journal: J Exp Med Date: 1991-10-01 Impact factor: 14.307

10. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.

Authors: J C Guéry; A Sette; J Leighton; A Dragomir; L Adorini
Journal: J Exp Med Date: 1992-05-01 Impact factor: 14.307

2 in total

1. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.

Authors: L C Harrison; M Dempsey-Collier; D R Kramer; K Takahashi
Journal: J Exp Med Date: 1996-12-01 Impact factor: 14.307

2. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.

Authors: J C Guéry; M Neagu; G Rodriguez-Tarduchy; L Adorini
Journal: J Exp Med Date: 1993-05-01 Impact factor: 14.307

2 in total